Physicochemical and biological characterization of a bispecific antibody in a CrossMab/KIH format that targets EGFR and VEGF-A
Safiat Ayinde(Center for Drug Evaluation and Research), Wen Jin Wu(Center for Drug Evaluation and Research)
Cited by 0
Related Papers
VPS34 regulates TSC1/TSC2 heterodimer to mediate RheB and mTORC1/S6K1 activation and cellular transformation
|Oncotarget|2016|28
Atezolizumab Induces Necroptosis and Contributes to Hepatotoxicity of Human Hepatocytes
|International Journal of Molecular Sciences|2023|16
Structural and functional characterization of IgG- and non-IgG-based T-cell-engaging bispecific antibodies
|Frontiers in Immunology|2024|12
Identification of a pharmacological approach to reduce ACE2 expression and development of an in vitro COVID-19 viral entry model
|Journal of Virus Eradication|2022|5